Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad-Ali Jenabian

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Retrovirology|December 24, 2013
Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replicationAnnie Bernier, Aurélie Cleret-Buhot, Yuwei Zhang, et al.
Retrovirology|August 25, 2016
New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapyVanessa Sue Wacleche, Jean-Philippe Goulet, Annie Gosselin, et al.
AIDS (London, England)|August 14, 2018
HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapyCecilia T Costiniuk, Syim Salahuddin, Omar Farnos, et al.
Ebiomedicine|August 23, 2024
Altered memory CCR6<sup>+</sup> Th17-polarised T-cell function and biology in people with HIV under successful antiretroviral therapy and HIV elite controllersAlexis Yero, Jean-Philippe Goulet, Tao Shi, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2016
Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary siteYiying Huang, Md Tozammel Hoque, Mohammad-Ali Jenabian, et al.
AIDS Research and Treatment|March 20, 2018
Nasal Nitric Oxide Levels in HIV Infection: A Cross-Sectional StudyCecilia T Costiniuk, Vikram Mehraj, Jean-Pierre Routy, et al.
BMJ Open|January 20, 2019
Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activationCecilia T Costiniuk, Zahra Saneei, Jean-Pierre Routy, et al.
International Journal of Behavioral Medicine|October 4, 2023
Knowledge of Cannabinoid Content Among People Living with HIV Who Use Cannabis: a Daily Diary StudySophie G Coelho, Sergio Rueda, Cecilia T Costiniuk, et al.
Journal of Clinical Medicine Research|June 27, 2020
Purifying Selection in Human Immunodeficiency Virus-1 <i>pol</i> Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral TherapyRalph-Sydney Mboumba Bouassa, Helene Pere, Christian Diamant Mossoro-Kpinde, et al.
Pathogens (Basel, Switzerland)|April 30, 2021
Velocity Gradient Separation Reveals a New Extracellular Vesicle Population Enriched in miR-155 and Mitochondrial DNAMyriam Vaillancourt, Audrey Hubert, Caroline Subra, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Retrovirology|December 24, 2013
Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replicationAnnie Bernier, Aurélie Cleret-Buhot, Yuwei Zhang, et al.
Retrovirology|August 25, 2016
New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapyVanessa Sue Wacleche, Jean-Philippe Goulet, Annie Gosselin, et al.
AIDS (London, England)|August 14, 2018
HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapyCecilia T Costiniuk, Syim Salahuddin, Omar Farnos, et al.
Ebiomedicine|August 23, 2024
Altered memory CCR6<sup>+</sup> Th17-polarised T-cell function and biology in people with HIV under successful antiretroviral therapy and HIV elite controllersAlexis Yero, Jean-Philippe Goulet, Tao Shi, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2016
Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary siteYiying Huang, Md Tozammel Hoque, Mohammad-Ali Jenabian, et al.
AIDS Research and Treatment|March 20, 2018
Nasal Nitric Oxide Levels in HIV Infection: A Cross-Sectional StudyCecilia T Costiniuk, Vikram Mehraj, Jean-Pierre Routy, et al.
BMJ Open|January 20, 2019
Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activationCecilia T Costiniuk, Zahra Saneei, Jean-Pierre Routy, et al.
International Journal of Behavioral Medicine|October 4, 2023
Knowledge of Cannabinoid Content Among People Living with HIV Who Use Cannabis: a Daily Diary StudySophie G Coelho, Sergio Rueda, Cecilia T Costiniuk, et al.
Journal of Clinical Medicine Research|June 27, 2020
Purifying Selection in Human Immunodeficiency Virus-1 <i>pol</i> Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral TherapyRalph-Sydney Mboumba Bouassa, Helene Pere, Christian Diamant Mossoro-Kpinde, et al.
Pathogens (Basel, Switzerland)|April 30, 2021
Velocity Gradient Separation Reveals a New Extracellular Vesicle Population Enriched in miR-155 and Mitochondrial DNAMyriam Vaillancourt, Audrey Hubert, Caroline Subra, et al.
Pageof 11